Joel Greenblatt's CRL Position Overview
Joel Greenblatt (via Gotham Asset Management, LLC) currently holds 0 shares of Charles River Laboratories International, Inc. (CRL) worth $0, representing 0.00% of the portfolio. First purchased in , this recently established position has been held for 0 quarters.
Based on recent 13F filings, Joel Greenblatt has initiated a new position in CRL, representing a fresh investment thesis on this company. Largest addition occurred in Q2 2025, adding 114,384 shares. Largest reduction occurred in Q2 2017, reducing 113,999 shares.
Analysis based on 13F filings available since 2013 Q2
Joel Greenblatt's Charles River Laboratories International (CRL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Charles River Laboratories International (CRL) Trades by Joel Greenblatt
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| No data available | ||||
Joel Greenblatt's Charles River Laboratories International Investment FAQs
According to the latest 13F filing for Q3 2025, Joel Greenblatt's firm, Gotham Asset Management, LLC, owns 315,755 shares of Charles River Laboratories International, Inc. (CRL), valued at approximately $49.4 M.
As of the Q3 2025 filing, Charles River Laboratories International, Inc. (CRL) represents approximately 0.22% of Joel Greenblatt's publicly disclosed stock portfolio, making it one of their key holdings.
Joel Greenblatt's peak holding in Charles River Laboratories International, Inc. (CRL) was 315,755 shares, as reported at the end of Q3 2025.